Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab

Eosinophilia-related coronary vasospasm is a diagnosis to consider in patients with chest pain and eosinophilia. Indefinite treatment aiming to normalize absolute eosinophil counts is warranted. In this setting, benralizumab is a promising steroid-free treatment regimen and deserves further investigation.

Automated summary

Eosinophilia-related coronary vasospasm should be considered in patients with chest pain and elevated eosinophil counts. Treatment aiming to normalize absolute eosinophil counts is essential, with benralizumab showing promise as a steroid-free option that warrants further investigation.